MIRA INFORM REPORT

 

 

Report Date :

18.10.2012

 

IDENTIFICATION DETAILS

 

Name :

BIOTECH INTERNATIONAL LIMITED

 

 

Registered Office :

Vipps Centre, 2 LSC, Block EFGH, Masjid Moth, Greater Kailash- II, New Delhi- 110048

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

08.02.1993

 

 

Com. Reg. No.:

55-052056

 

 

Capital Investment / Paid-up Capital :

Rs.24.836 millions

 

 

CIN No.:

[Company Identification No.]

U24297DL1993PLC052056

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Biopesticides and Bednets.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (37)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 450000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track. It has large working capital requirements, exposure to implementation and demand related risks associated with its upcoming unit for manufacturing long-lasting-insecticidal mosquito bed nets (LLIN), small scale of operations.

 

However, trade relations are reported as fair. Business is active. Payments are reported to be slow but correct.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

India is developing into an open-market economy, yet traces of its past autarkic policies remain. Economic liberalization, including industrial deregulation, privatization of state-owned enterprises, and reduced controls on foreign trade and investment, began in the early 1990s and has served to accelerate the country's growth, which has averaged more than 7% per year since 1997. India's diverse economy encompasses traditional village farming, modern agriculture, handicrafts, a wide range of modern industries, and a multitude of services. Slightly more than half of the work force is in agriculture, but services are the major source of economic growth, accounting for more than half of India's output, with only one-third of its labor force. India has capitalized on its large educated English-speaking population to become a major exporter of information technology services and software workers. In 2010, the Indian economy rebounded robustly from the global financial crisis - in large part because of strong domestic demand - and growth exceeded 8% year-on-year in real terms. However, India's economic growth in 2011 slowed because of persistently high inflation and interest rates and little progress on economic reforms. High international crude prices have exacerbated the government's fuel subsidy expenditures contributing to a higher fiscal deficit, and a worsening current account deficit. Little economic reform took place in 2011 largely due to corruption scandals that have slowed legislative work. India's medium-term growth outlook is positive due to a young population and corresponding low dependency ratio, healthy savings and investment rates, and increasing integration into the global economy. India has many long-term challenges that it has not yet fully addressed, including widespread poverty, inadequate physical and social infrastructure, limited non-agricultural employment opportunities, scarce access to quality basic and higher education, and accommodating rural-to-urban migration.

Source : CIA

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

BB+ (Long term Rating)

Rating Explanation

Moderate risk of default

Date

19.07.2012

 

Rating Agency Name

CRISIL

Rating

A4 (Short term Rating)

Rating Explanation

Minimal degree of safety and very high credit risk

Date

19.07.2012

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

LOCATIONS

 

Registered Office :

VIPPS Centre, 2, Local Shopping Centre, Block EFGH, Masjid Moth, Greater Kailash- II, New Delhi- 110048, India

Tel. No.:

91-11-29227228/29220546/29220547/29213446/29218347

Fax No.:

91-11-29229166/29223089

E-Mail :

cs@biotech-int.com

mail@biotech-int.com

info@biotech-int.com

Website :

www.biotech-int.com

 

 

Factory:

B-21, Site-C, Surajbpur Industrial Area, Gautam Budh Nagar, Greater Noida-201306, Uttar Pradesh, India

 

 

 DIRECTORS

 

As on 30.09.2011

 

Name :

Mr. Vivek Singhal

Designation :

Director

Address :

24, Palam Marg Vasant Vihar,  New Delhi-110057, India

Date of Birth/Age :

26.06.1940

Date of Appointment :

08.02.1993

DIN No.:

01046325

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U74899DL1971PTC005833

CHEMICALS INTERNATIONAL PRIVATE LIMITED

Managing director

17/11/2007

28/12/1971

-

Active

NO

2

U24297DL1993PLC052056

BIOTECH INTERNATIONAL LIMITED

Director

08/02/1993

08/02/1993

-

Active

NO

3

U74899DL1993PLC054495

COMPUTRONICS INTERNATIONAL LIMITED

Director

16/07/1993

16/07/1993

-

Active

NO

4

U45400DL2007PTC161544

SIRIUS DESIGNS & EVENTS PRIVATE LIMITED

Director

02/04/2007

02/04/2007

-

Strike off

NO

 

 

Name :

Mrs. Manjula Singhal

Designation :

Director

Address :

24, Palam Marg Vasant Vihar,  New Delhi-110057, India

Date of Birth/Age :

09.11.1943

Date of Appointment :

25.08.1994

DIN No.:

01046331

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U74899DL1971PTC005833

CHEMICALS INTERNATIONAL PRIVATE LIMITED

Director

15/10/1971

15/10/1971

-

Active

NO

2

U74899DL1993PLC054495

COMPUTRONICS INTERNATIONAL LIMITED

Director

16/07/1993

16/07/1993

-

Active

NO

3

U24297DL1993PLC052056

BIOTECH INTERNATIONAL LIMITED

Director

25/08/1994

25/08/1994

-

Active

NO

 

 

Name :

Mr. Saurabh Singhal

Designation :

Managing director

Address :

24, Palam Marg Vasant Vihar, New Delhi-110057, India

Date of Birth/Age :

11.08.1968

Date of Appointment :

08.02.1993

DIN No.:

01046335

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24297DL1993PLC052056

BIOTECH INTERNATIONAL LIMITED

Managing director

01/07/2011

08/02/1993

-

Active

NO

2

U74899DL1993PLC054495

COMPUTRONICS INTERNATIONAL LIMITED

Director

16/07/1993

16/07/1993

04/07/2011

Active

NO

3

U45400DL2007PTC161544

SIRIUS DESIGNS & EVENTS PRIVATE LIMITED

Director

02/04/2007

02/04/2007

-

Strike off

NO

4

U74899DL1971PTC005833

CHEMICALS INTERNATIONAL PRIVATE LIMITED

Director

29/09/2012

14/03/2012

-

Active

NO

 

 

Name :

Jagdish Chand Agarwal

Designation :

Director

Address :

C-501, Vrindawan Garden CGHS Limited, Plot 10, Sector 12, Dwarka, New Delhi-110075, India

Date of Birth/Age :

05.09.1956

Date of Appointment :

27.09.2002

DIN No.:

01056196

 

 

Name :

Mr. Surendra Kumar Aggarwal

Designation :

Director

Address :

H2B/824, Sukhdev Vihar, Opp-Defence Colony, Kotla Mubarakpur, New Delhi- 110003, India

Date of Birth/Age :

05.08.1965

Date of Appointment :

27.09.2002

DIN No.:

01056201

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24297DL1993PLC052056

BIOTECH INTERNATIONAL LIMITED

Director

27/09/2002

27/09/2002

-

Active

NO

2

U74899DL1971PTC005833

CHEMICALS INTERNATIONAL PRIVATE LIMITED

Director

30/09/2009

30/09/2009

-

Active

NO

 

 

Name :

Mr. Hariom Bansal

Designation :

Director

Address :

Pocket-K, 96 A Shaikh Saria, Phase –II, New Delhi-110017, India

Date of Birth/Age :

15.08.1944

Date of Appointment :

30.06.2006

DIN No.:

01086580

Other Directorship:

 

 

Name :

Debabrata Kanungo

Designation :

Director

Address :

H. N.294, Sec-21D, Faridabad-121005, Haryana, India 

Date of Birth/Age :

21.06.1949

Date of Appointment :

29.09.2012

DIN No.:

03612779

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24297DL1993PLC052056

BIOTECH INTERNATIONAL LIMITED

Director

29/09/2012

20/12/2011

-

Active

NO

2

U85320OR2003NPL007082

KALPATARU CENTRE FOR GREEN EARTH CARE SERVICES

Director

05/03/2012

05/03/2012

-

Active

NO

 

 

KEY EXECUTIVES

 

Name :

Siddharth Sharma

Designation :

Secretary

Address :

2B, A/2B, Paschim Vihar, New Delhi-110063, India

Date of Birth/Age :

07.04.1978

Date of Appointment :

19.08.2010

PAN No.:

AXJPS9454L

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2011  

 

Names of Shareholders

 

No. of Shares

 Manvi Investment Private Limited, India

 

112500

Vivek Singhal (HUF)

Karta - Shri Vivek Singhal

 

270000

Ravi Singhal

Vivek Singhal

 

236250

Vivek Singhal

Manjula Singhal

 

335250

Manjula Singhal

Vivek Singhal

 

335250

Saurabh Singhal

Shabnam Singhal

 

283050

Shabnam Singhal

Saurabh Singhal

 

45000

Chemicals International Private Limited, India

 

641268

Computronics International Limited, India

 

225000

Total

 

2483568

 

Equity Share Break up (Percentage of Total Equity)

 

As on 30.09.2011

 

Category

Percentage

Bodies corporate

39.00

Directors or relatives of Directors

61.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Biopesticides and Bednets.

 

 

Products/ Services :

ITC CODE NO.

PRODUCT/ SERVICES DESCRIPTION

0108

Biopesticidies

0124

Mosquito Bednets

0174

Business Centre Services

 

PRODUCTION STATUS AS ON 31.03.2011

 

Particulars

Unit

Actual Production

Biolep

Kg.

13554

Bacterial/ Sphericide

Kg.

329255

Neemarin

Ltr.

406639

Bioderma

Kg.

248005

Biomonas

Kg.

30007

Biovirus

Ltr.

23255

Biotrap

Nos.

0

Other Biopesticide

Nos.

0

 

Kg.

6603

 

 

 

Biofertilizers

 

 

Bioboost Granules

Kg.

0

Bioboost Liquid

Ltr.

0

Biophos

Ltr.

51641

Biospirilium

Ltr.

40

Other Biofertilizers

Ltr.

9881

Bedness (Mosquito Net)

Nos.

44466

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

  • Canara Bank, International Operation Branch, A-27, Hauz Khas, New Delhi - 110016, India

 

  • HDFC Bank Limited

 

  • State Bank of India

 

 

Facilities :

Secured Loan

31.03.2011

(Rs. in Millions)

31.03.2010

(Rs. in Millions)

WORKING CAPITAL LOANS

 

 

Open Cash Credit from Canara Bank

74.917

66.511

Bills Discounting from Canara Bank

0.000

2.245

Over Draft from Canara Bank

4.798

5.618

Over Draft Limit from State Bank of India

7.263

2.841

Bills Discounting Can Bank Factor Limited

0.193

27.059

LOAN AGAINST VEHICLES

 

 

Reliance Capital Limited

0.000

0.413

HDFC Bank Limited

0.310

0.000

Total

87.481

104.687

 

NOTES:

 

1. The Working Capital loan from Canara Bank is secured by way of hypothecation of stock of raw materials, finished goods. Semi finished goods and hook debts upto 180 days and mortgage of personal property or Managing Director at C-5/12. Safdarjung Development Area, New Delhi as well as personal guaratnee of directors Shri Vivek Singhal, Shri Saurabh Singhal and Smt. Manjula Singhal. Land and Factory building contracted thereon at B-21, Site-C, Surajpur Industrial, Greater Noida (U.P.) is also available as collalral security. Further the loan is secured by the corporate guarantee or M/s. Chemicals International Private Limited.

 

2. Over Draft from Canara Bank and State Bank of India are secured against the pledged of FDR's belonging to the Directors/CEO of the company.

 

3. The Sale bills Discounting Limit from Canbank Factors Limited is secured by mortgage of property namely Vipps Centre at 2, LSC, Masjid Moth, GK-I1, New Delhi owned by VIPPS INDIA (DELHI) a partnership firm wherein Mr Saurabh Singhal and Vivek Singhal (HUF) are among the partners. The limit is further secured by guarantee of VIPPS India (Delhi) as well as corporate guarantee of Chemicals International Private Limited as well as personal guarantee of directors Mr. Vivek Singhal, Mr. Saurabh Singhal and Mrs. Manjula Singhal.

 

4. Loan against vehicles are secured against hypothecation or vehicles. Amount due for repayment within one year amount to Rs. 0.109 Million (Previous Year Rs.0.413 Million).

 

Unsecured Loan

31.03.2011

(Rs. in Millions)

31.03.2010

(Rs. in Millions)

Deposits From Directors

6.149

6.149

Total

6.149

6.149

 

NOTE:

 

The above unsecured loan is in subordination from the Promoter Directors as per the stipulations and in fulfilments of the terms and condition of working capital loan sanclioned and availed by the company from the Canara Bank.

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Thakur, Vaidyanath Aiyer and Company

Chartered Accountants

Address :

221-223, Deen Dayal Marg, New Delhi- 110002, India

Tel. No.:

91-11-23236958-60/23237772

Fax No.:

91-11-23230831

E-Mail :

tvand@vsnl.com   

tvande@rediffmail.com

PAN No.:

AAAFT3096M

 

 

Related Parties :

  • Vivek Singhal (HUF)
  • VIPPS India (Delhi)
  • Chemicals International Private Limited
  • Computronics Business Centre, Proprietor Chemicals International Private Limited
  • Manvi Investments Private Limited

 

 

CAPITAL STRUCTURE

 

As on 31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

3000000

Equity Shares

Rs.10/- each

Rs.30.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

2483568

Equity Shares

Rs.10/- each

Rs.24.836 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

24.836

24.836

13.933

2] Share Application Money

0.000

0.000

8.500

3] Reserves & Surplus

87.670

71.286

59.956

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

112.506

96.122

82.389

LOAN FUNDS

 

 

 

1] Secured Loans

87.481

104.687

66.104

2] Unsecured Loans

6.149

6.149

6.149

TOTAL BORROWING

93.630

110.836

72.253

DEFERRED TAX LIABILITIES

0.000

0.178

0.401

 

 

 

 

TOTAL

206.136

207.136

155.043

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

33.975

35.890

39.430

Capital work-in-progress

16.599

16.746

8.671

 

 

 

 

INVESTMENT

0.286

0.286

0.286

DEFERRED TAX ASSETS

0.298

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

56.462

39.692

30.064

 

Sundry Debtors

130.412

205.307

150.545

 

Cash & Bank Balances

103.891

25.390

17.243

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

56.659

60.090

36.312

Total Current Assets

347.424

330.479

234.164

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

156.247

104.277

68.502

 

Other Current Liabilities

29.077

32.691

28.964

 

Provisions

7.122

39.297

30.042

Total Current Liabilities

192.446

176.265

127.508

Net Current Assets

154.978

154.214

106.656

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

206.136

207.136

155.043

 

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

377.515

310.563

308.156

 

 

Business Centre Services

15.056

13.753

14.024

 

 

Other Income

3.802

2.228

1.933

 

 

TOTAL                                     (A)

396.373

326.544

324.113

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Raw Material Consumed

166.965

126.591

85.013

 

 

Excise Duty on Increase/ (Decrease) of Finished Stocks

0.424

(0.018)

(0.657)

 

 

Purchases / Cost of trading Goods

9.431

4.946

59.818

 

 

Manufacturing and Processing Expenses

19.225

14.079

25.410

 

 

Employees Remuneration and Benefits

26.482

22.387

17.795

 

 

Administration, Selling and Other Expenses

130.288

110.291

74.736

 

 

Increase/ Decrease in Stock of Finished Goods

(5.240)

5.236

(4.110)

 

 

TOTAL                                     (B)

347.575

283.512

258.005

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

48.798

43.032

66.108

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

15.324

16.053

14.492

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

33.474

26.979

51.616

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

4.315

4.448

4.943

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                              (G)

29.159

22.531

46.673

 

 

 

 

 

Less

TAX                                                                  (H)

9.879

11.563

18.741

 

 

 

 

 

 

PROFIT AFTER TAX (G- H)                               (I)

19.280

10.968

27.932

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

40.537

33.572

11.694

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Proposed Dividend

2.484

2.484

2.787

 

 

Tax on Dividend

0.412

0.422

0.474

 

 

Amount Transfered to General Reserve

1.928

1.097

2.793

 

BALANCE CARRIED TO THE B/S

54.993

40.537

33.572

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

12.609

6.565

3.783

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Material

78.475

75.548

11.593

 

TOTAL IMPORTS

78.475

75.548

11.593

 

 

 

 

 

 

Earnings Per Share (Rs.)

7.76

6.44

28.44

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

4.86

3.36

8.62

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

7.72

7.25

15.15

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

7.65

7.25

15.15

 

 

 

 

 

Return on Investment (ROI)

(PBT/Net worth)

 

0.26

0.23

0.57

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Net worth)

 

2.54

2.99

2.42

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.81

1.87

1.84

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

------

22]

Litigations that the firm / promoter involved in

------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

------

26]

Buyer visit details

------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

OPERATIONS:

 

During the year, the company recorded a sale revenue of Rs. 409.490 Millions as against Rs 333.901 Millions during last year thereby recorded an increase in its sale turnover by 22.64 %. The Profit before taxes is Rs. 29.159 Millions as against Rs 22.530 Millions during last year. An amount of Rs. 1.928 Millions is being transferred to General Reserves as against Rs. 1.097 Millions during the Last Year.

 

FUTURE OUTLOOK:

 

The Company is determined to enhance overall growth of the company in near future and following activities are already being undertaken

 

• The Company is hiring new human resources for exploring the untapped markets of Jharkhand, Bihar for promotion of Public Health Products.

 

• Purchase of technology to manufacture liquid Bti and the same is being registered with Central Insecticides Board. Bacticide DT is also undergoing registration. With the introduction of these two different formulations, we will be in a position to give a choice of formulations to their customers. Also, the introduction of Bacticide AS will be revenue stream for the company where non TAC products are required.

 

• Placing of orders for 1500 Ltr. fermentor, 1500 Ltr. Holding Tank and 75 Ltr. Seed fermentor to cater to the growing demands of their products. These fermentors would be used to manufacture both agricultural and public health products. Because of the installation of these fermentors, we would be able to increase their production capacity to at least ten fold.

 

• Further studies are being conducted at various agricultural universities in different geographical locations so as to enable them to get the leaf left expansion on different crops. This would also enable them to bid for tenders where such details are sought/looked into.

 

• New Teams are being build to spearhead trade sales of their agricultural biological products through the traditional dealer distributor net work. In the coming years their presence in the dealer distributor net work system will enable them to establish their brands amongst the farmers

 

 

CONTINGENT LIABILITIES AS ON 31.03.2011

 

(a) Guarantee issued by bank on behalf of the company as at 31.03.2011 amounted to Rs.5.227 Millions (Previous year Rs 6.719 Millions) and Letter of Credit Rs.62.815 Millions (Previous year Rs.30.728 Millions)

 

(b) The Income Tax Department has imposed penalty for Rs 3.921 Millions u/s 271(l)(c) of the Income Tax act subsequent to (he order passed under section 148 for the A.Y 2001-2002 by disallowing deduction u/s 801A claimed by the company against which the company has filed appeal before C1T(A), New Delhi which is still pending.

 

(c) The Income Tax department has issued notice dated 27.03.2009 for reopening of the case u/s 148 for the A.Y. 2002-2003 alleging that the deduction u/s 80IA amounting Rs.5.680 Millions has been wrongly claimed. Against the notice of the department, the company has filed writ in the Delhi High Court which is still pending.

 

(d) Liability, if any of taxes and duties to be determined on completion of assessment.

 

 

BANKERS CHARGES REPORT AS PER REGISTRY

 

Corporate identity number of the company

U24297DL1993PLC052056

Name of the company

BIOTECH INTERNATIONAL LIMITED

Address of the registered office or of the principal place of  business in India of the company

Vipps Centre, 2 LSC, Block EFGH, Masjid Moth, Greater Kailash- II, New Delhi- 110048, India

Email: cs@biotech-int.com

This form is for

Modification of charge

Charge identification (ID) number of the charge to be modified

80013549

Type of charge

Immovable property

Particular of charge holder

Canara Bank, International Operation Branch, A-27, Hauz Khas, New Delhi - 110016, India

Email: cb2369@canarabank.com

Nature of instrument creating charge

Memorandum of Extension of Equitable Mortgage

Date of instrument Creating the charge

08.08.2012

Amount secured by the charge

Rs.180.000 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest

As may be specified by the bank from time to time.

 

Terms of Repayment

As per agreement

 

Margin

As per agreement

 

Extent and Operation of the charge

100% to secure various credit facilities of Rs. 180.000 Millions sanctioned to the company, such as CC Rs. 90.000 Millions, ILC/FLC Rs. 65.000 Millions, BG Rs. 20.000 Millions and FBE/FDB Rs. 5.000 Millions (SL Rs. 2.000 Millions PC), detailed as per annexure-1 attached.

Short particulars of the property or asset(s) charged (including complete address and location of the property)

EMT of industrial Plot situated at B-21 , Site-C , Surajpur Industrial Area, Greater Noida allotted by UPSIDC and Building constructed thereon in the name of Biotech International Limited

 

Corporate Guarantee of Chemicals International Private Limited

Particulars of the present modification

Extent of operation of charge over immovable property situated at: industrial Plot situated at B-21, Site-C, Surajpur Industrial Area, Greater Noida, stands enhanced from Rs. 170.000 Millions to Rs. 180.000 Millions, to secure various credit facilities of Rs. 180.000 Millions sanctioned to the company, such as CC Rs. 90.000 Millions, ILC/FLC Rs. 65.000 Millions, BG Rs. 20.000 Millions and FBE/FDB Rs. 5.000 Millions (SL Rs. 2.000 Millions PC), Other T and C as per agreement.

 

FIXED ASSETS:

 

  • Freehold Land
  • Factory Building
  • Business Centre Renovation
  • Plant and Machinery
  • Electrical Installations
  • Lab Equipments
  • Tools and Equipments
  • Office Equipments
  • Furniture and Fixtures
  • Vehicles
  • Intangible Assets (Software)

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration:

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration:

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime:

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws:

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards:

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government:

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package:

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report:

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.52.75

UK Pound

1

Rs.85.08

Euro

1

Rs.69.04

 

 

INFORMATION DETAILS

 

Report Prepared by :

MRI

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

4

--CREDIT LINES

1~10

4

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

37

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

 

NB

 

NEW BUSINESS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.